Published date: 8 June 2017

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 26 June 2017

Contract summary

Industry

  • Research and development consultancy services - 73200000

  • Design and execution of research and development - 73300000

  • Miscellaneous business and business-related services - 79900000

    • Miscellaneous health services - 85140000

Location of contract

Any region

Value of contract

£60,000 to £100,000

Procurement reference

ITT60432,1

Published date

8 June 2017

Closing date

26 June 2017

Contract start date

12 July 2017

Contract end date

13 September 2017

Contract type

Service contract

Procedure type

Open procedure

Any interested supplier may submit a tender in response to an opportunity notice.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

This is a notification that the Department is running a sub OJEU Open Procurement for the services described. - (for which see ITT ref number 60432,1).Interested suppliers need to register on the BMS system if they have not done so already. Details of registration can be found on the attached instructions document and link provided.

This Invitation to Tender relates to the procurement by open sub OJEU tender to award a Contract for the provision of consultancy services for Emergency Medicines Buffer Stocks.

DH is responsible for the security of supply of medicines and takes the lead in the prevention, mitigation and management of medicines supply problems within the UK. DH is also responsible for ensuring that plans are in place to prevent and respond to outbreaks of infectious disease and other threats to the health of the population including an influenza pandemic.

In the event of a pandemic or other health emergency it is likely that medicines supply will be disrupted. Supply disruptions could put an additional burden on the health system. Medicines may not be available to treat people and patients relying on their regular medicines for existing conditions could be faced with a lack of availability of these medicines. This impacts the health of these patients but could also lead to more hospitalisations and potentially deaths during a time when the pressure on the NHS is already great. The threat of a severe pandemic remains real and a major government priority.

This project has two separate deliverables:

Deliverable 1: A reproducible methodology, using a MCDA-based approach, to populate and update a ranked list of essential medicines for inclusion within the Essential Medicines Buffer Stock, to support procurement

Deliverable 2: A list of essential medicines for inclusion in the EMBS, ranked by the degree to which they are deemed essential, to satisfy various budget scenarios and a method for assessing their health benefits.

Bidders are required to refer to the procurement documentation for full details of the requirement. The Contract is expected to be for a period of up to 8 weeks, with extension options. See attached Procurement documents. DH reserves the right to not proceed to Contract for this requirement.

More information

Attachments

Links

Additional text

Completed bids must be submitted via the Department of Health BMS procurement system by not later than 11am on 26th June.

About the buyer

Contact name

Garry Raisbeck

Address

Department of Health, Quarry House, Quarry Hill
Leeds
LS2 7UE
England

Email

supplier.helpdesk@dh.gsi.gov.uk